Global Diabetic Neuropathic Pain Drug Market Research Report 2019

Table of Contents

Executive Summary

1 Diabetic Neuropathic Pain Drug Market Overview

• 1.1 Product Overview and Scope of Diabetic Neuropathic Pain Drug
• 1.2 Diabetic Neuropathic Pain Drug Segment by Type
  • 1.2.1 Global Diabetic Neuropathic Pain Drug Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 AZD-5213
  • 1.2.3 Clonidine Hydrochloride
  • 1.2.4 Duloxetine Hydrochloride DR
  • 1.2.5 E-52862
  • 1.2.6 Filgrastim
  • 1.2.7 GERPOOI
  • 1.2.8 GRC-17536
  • 1.2.9 Others
• 1.3 Diabetic Neuropathic Pain Drug Segment by Application
  • 1.3.1 Diabetic Neuropathic Pain Drug Consumption Comparison by Application (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Hospital
  • 1.3.4 Others
• 1.3 Global Diabetic Neuropathic Pain Drug Market by Region
  • 1.3.1 Global Diabetic Neuropathic Pain Drug Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Diabetic Neuropathic Pain Drug Market Size
  • 1.4.1 Global Diabetic Neuropathic Pain Drug Revenue (2014-2025)
  • 1.4.2 Global Diabetic Neuropathic Pain Drug Production (2014-2025)

2 Global Diabetic Neuropathic Pain Drug Market Competition by Manufacturers

• 2.1 Global Diabetic Neuropathic Pain Drug Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Diabetic Neuropathic Pain Drug Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Diabetic Neuropathic Pain Drug Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Diabetic Neuropathic Pain Drug Production Sites, Area Served, Product Types
• 2.5 Diabetic Neuropathic Pain Drug Market Competitive Situation and Trends
  • 2.5.1 Diabetic Neuropathic Pain Drug Market Concentration Rate
  • 2.5.2 Diabetic Neuropathic Pain Drug Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Diabetic Neuropathic Pain Drug Production Market Share by Regions

• 3.1 Global Diabetic Neuropathic Pain Drug Production Market Share by Regions
• 3.2 Global Diabetic Neuropathic Pain Drug Revenue Market Share by Regions (2014-2019)
• 3.3 Global Diabetic Neuropathic Pain Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Diabetic Neuropathic Pain Drug Production
  • 3.4.1 North America Diabetic Neuropathic Pain Drug Production Growth Rate (2014-2019)
  • 3.4.2 North America Diabetic Neuropathic Pain Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Diabetic Neuropathic Pain Drug Production
  • 3.5.1 Europe Diabetic Neuropathic Pain Drug Production Growth Rate (2014-2019)
  • 3.5.2 Europe Diabetic Neuropathic Pain Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Diabetic Neuropathic Pain Drug Production (2014-2019)
  • 3.6.1 China Diabetic Neuropathic Pain Drug Production Growth Rate (2014-2019)
  • 3.6.2 China Diabetic Neuropathic Pain Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Diabetic Neuropathic Pain Drug Production (2014-2019)
  • 3.7.1 Japan Diabetic Neuropathic Pain Drug Production Growth Rate (2014-2019)
  • 3.7.2 Japan Diabetic Neuropathic Pain Drug Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Diabetic Neuropathic Pain Drug Consumption by Regions

• 4.1 Global Diabetic Neuropathic Pain Drug Consumption by Regions
• 4.2 North America Diabetic Neuropathic Pain Drug Consumption (2014-2019)
• 4.3 Europe Diabetic Neuropathic Pain Drug Consumption (2014-2019)
• 4.4 China Diabetic Neuropathic Pain Drug Consumption (2014-2019)
• 4.5 Japan Diabetic Neuropathic Pain Drug Consumption (2014-2019)

5 Global Diabetic Neuropathic Pain Drug Production, Revenue, Price Trend by Type

• 5.1 Global Diabetic Neuropathic Pain Drug Production Market Share by Type (2014-2019)
• 5.2 Global Diabetic Neuropathic Pain Drug Revenue Market Share by Type (2014-2019)
• 5.3 Global Diabetic Neuropathic Pain Drug Price by Type (2014-2019)
• 5.4 Global Diabetic Neuropathic Pain Drug Production Growth by Type (2014-2019)

6 Global Diabetic Neuropathic Pain Drug Market Analysis by Applications

• 6.1 Global Diabetic Neuropathic Pain Drug Consumption Market Share by Application (2014-2019)
• 6.2 Global Diabetic Neuropathic Pain Drug Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Diabetic Neuropathic Pain Drug Business

• 7.1 Astellas Pharma Inc.
  • 7.1.1 Astellas Pharma Inc. Diabetic Neuropathic Pain Drug Production Sites and Area Served
  • 7.1.2 Diabetic Neuropathic Pain Drug Product Introduction, Application and Specification
  • 7.1.3 Astellas Pharma Inc. Diabetic Neuropathic Pain Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 AstraZeneca Plc
  • 7.2.1 AstraZeneca Plc Diabetic Neuropathic Pain Drug Production Sites and Area Served
  • 7.2.2 Diabetic Neuropathic Pain Drug Product Introduction, Application and Specification
  • 7.2.3 AstraZeneca Plc Diabetic Neuropathic Pain Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 BioDelivery Sciences International, Inc.
  • 7.3.1 BioDelivery Sciences International, Inc. Diabetic Neuropathic Pain Drug Production Sites and Area Served
  • 7.3.2 Diabetic Neuropathic Pain Drug Product Introduction, Application and Specification
  • 7.3.3 BioDelivery Sciences International, Inc. Diabetic Neuropathic Pain Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Boehringer Ingelheim GmbH
  • 7.4.1 Boehringer Ingelheim GmbH Diabetic Neuropathic Pain Drug Production Sites and Area Served
  • 7.4.2 Diabetic Neuropathic Pain Drug Product Introduction, Application and Specification
  • 7.4.3 Boehringer Ingelheim GmbH Diabetic Neuropathic Pain Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Daiichi Sankyo Company, Limited
  • 7.5.1 Daiichi Sankyo Company, Limited Diabetic Neuropathic Pain Drug Production Sites and Area Served
  • 7.5.2 Diabetic Neuropathic Pain Drug Product Introduction, Application and Specification
  • 7.5.3 Daiichi Sankyo Company, Limited Diabetic Neuropathic Pain Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Dong-A Socio Group
  • 7.6.1 Dong-A Socio Group Diabetic Neuropathic Pain Drug Production Sites and Area Served
  • 7.6.2 Diabetic Neuropathic Pain Drug Product Introduction, Application and Specification
  • 7.6.3 Dong-A Socio Group Diabetic Neuropathic Pain Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Eli Lilly and Company
  • 7.7.1 Eli Lilly and Company Diabetic Neuropathic Pain Drug Production Sites and Area Served
  • 7.7.2 Diabetic Neuropathic Pain Drug Product Introduction, Application and Specification
  • 7.7.3 Eli Lilly and Company Diabetic Neuropathic Pain Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Glenmark Pharmaceuticals Ltd.
  • 7.8.1 Glenmark Pharmaceuticals Ltd. Diabetic Neuropathic Pain Drug Production Sites and Area Served
  • 7.8.2 Diabetic Neuropathic Pain Drug Product Introduction, Application and Specification
  • 7.8.3 Glenmark Pharmaceuticals Ltd. Diabetic Neuropathic Pain Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Hydra Biosciences, Inc.
  • 7.9.1 Hydra Biosciences, Inc. Diabetic Neuropathic Pain Drug Production Sites and Area Served
  • 7.9.2 Diabetic Neuropathic Pain Drug Product Introduction, Application and Specification
  • 7.9.3 Hydra Biosciences, Inc. Diabetic Neuropathic Pain Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Immune Pharmaceuticals Inc.
  • 7.10.1 Immune Pharmaceuticals Inc. Diabetic Neuropathic Pain Drug Production Sites and Area Served
  • 7.10.2 Diabetic Neuropathic Pain Drug Product Introduction, Application and Specification
  • 7.10.3 Immune Pharmaceuticals Inc. Diabetic Neuropathic Pain Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Laboratorios Del Dr. Esteve S.A.
• 7.12 Lohocla Research Corporation
• 7.13 Mertiva AB
• 7.14 Novaremed
• 7.15 Pharmaleads
• 7.16 RAPID Pharmaceuticals AG
• 7.17 Relmada Therapeutics, Inc.
• 7.18 Sphaera Pharma Pvt. Ltd.
• 7.19 Theravasc, Inc.

8 Diabetic Neuropathic Pain Drug Manufacturing Cost Analysis

• 8.1 Diabetic Neuropathic Pain Drug Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Diabetic Neuropathic Pain Drug
• 8.4 Diabetic Neuropathic Pain Drug Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Diabetic Neuropathic Pain Drug Distributors List
• 9.3 Diabetic Neuropathic Pain Drug Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Diabetic Neuropathic Pain Drug Market Forecast

• 11.1 Global Diabetic Neuropathic Pain Drug Production, Revenue Forecast
  • 11.1.1 Global Diabetic Neuropathic Pain Drug Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Diabetic Neuropathic Pain Drug Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Diabetic Neuropathic Pain Drug Price and Trend Forecast (2019-2025)
• 11.2 Global Diabetic Neuropathic Pain Drug Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Diabetic Neuropathic Pain Drug Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Diabetic Neuropathic Pain Drug Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Diabetic Neuropathic Pain Drug Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Diabetic Neuropathic Pain Drug Production, Revenue Forecast (2019-2025)
• 11.3 Global Diabetic Neuropathic Pain Drug Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Diabetic Neuropathic Pain Drug Consumption Forecast (2019-2025)
  • 11.3.2 Europe Diabetic Neuropathic Pain Drug Consumption Forecast (2019-2025)
  • 11.3.3 China Diabetic Neuropathic Pain Drug Consumption Forecast (2019-2025)
  • 11.3.4 Japan Diabetic Neuropathic Pain Drug Consumption Forecast (2019-2025)
• 11.4 Global Diabetic Neuropathic Pain Drug Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Diabetic Neuropathic Pain Drug Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List